Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinal Vascular Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00088283
What this trial is testing

Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Retinal Vein Occlusion
Eyetech Pharmaceuticals 90
Not applicableEnded earlyNCT02088151
What this trial is testing

Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina

Who this might be right for
Macular EdemaCentral Serous ChorioretinopathyRetinal Vein Occlusion+2 more
Insel Gruppe AG, University Hospital Bern 18
Not applicableStudy completedNCT02579837
What this trial is testing

CLEAR SIGHT: A Trial of Non-Mydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye Disease

Who this might be right for
Diabetes MellitusDiabetic Retinopathy
Western University, Canada 742
Not applicableStudy completedNCT00050492
What this trial is testing

Biological Markers in Retinal Vasculitis

Who this might be right for
Retinal Vasculitis
National Eye Institute (NEI) 200
Testing effectiveness (Phase 2)UnknownNCT05429229
What this trial is testing

Effect of Topical Antioxidants in Dry Eye Disease and Diabetic Retinopathy

Who this might be right for
Dry Eye SyndromesDiabetic RetinopathyOxidative Stress+1 more
Adolfo Daniel Rodriguez-Carrizalez 78
Early research (Phase 1)Study completedNCT02099981
What this trial is testing

Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients

Who this might be right for
Diabetic Retinopathy
University of Minnesota 34
Not applicableStudy completedNCT05542381
What this trial is testing

The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain

Who this might be right for
Age-Related Macular Degeneration
Virginia Polytechnic Institute and State University 64
Testing effectiveness (Phase 2)Study completedNCT01468844
What this trial is testing

Minocycline to Treat Central Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
National Eye Institute (NEI) 6
Large-scale testing (Phase 3)Study completedNCT00637377
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Bayer 1,240
Early research (Phase 1)Ended earlyNCT00969293
What this trial is testing

Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Fovea Pharmaceuticals SA 11
Large-scale testing (Phase 3)Study completedNCT00509795
What this trial is testing

Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)

Who this might be right for
Macular Degeneration
Regeneron Pharmaceuticals 1,217
Testing effectiveness (Phase 2)Study completedNCT03238963
What this trial is testing

A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.

Who this might be right for
Diabetic Retinopathy
Boehringer Ingelheim 79
Not applicableStudy completedNCT00797134
What this trial is testing

Retinal Thickness Analysis Using Optical Coherence Tomography

Who this might be right for
Diabetic Retinopathy
Association for Innovation and Biomedical Research on Light and Image 45
Testing effectiveness (Phase 2)UnknownNCT00745511
What this trial is testing

Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Ora Bio Ltd. 96
Not applicableUnknownNCT04499768
What this trial is testing

A Longitudinal Study of Choroidal Changes After Cataract Surgery in Eyes With Diabetic Retinopathy

Who this might be right for
Optical Coherence TomographyDiabetic RetinopathyChoroid
Ruijin Hospital 46
Not applicableStudy completedNCT03313817
What this trial is testing

Pre and Post-arterial Recanalization Imaging of Central Retinal Artery Occlusions (CRAO)

Who this might be right for
Retinal Artery OcclusionMagnetic Resonance ImagingDiagnosis+2 more
Fondation Ophtalmologique Adolphe de Rothschild 63
Large-scale testing (Phase 3)Study completedNCT00567697
What this trial is testing

Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO

Who this might be right for
Central Retinal Vein OcclusionMacular Edema
Aleris Helse 32
Not applicableEnded earlyNCT00001310
What this trial is testing

Tissue Studies of Human Eye Diseases

Who this might be right for
Retinal DiseaseCorneal DiseaseDiabetic Retinopathy+2 more
National Eye Institute (NEI) 3,833
Not applicableStudy completedNCT07255326
What this trial is testing

Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes

Who this might be right for
Diabetic RetinopathyType 1 DiabetesOmega 3 Fatty Acids
University of Faisalabad 70
Large-scale testing (Phase 3)Study completedNCT04964089
What this trial is testing

Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 557
Next Page